Storici Paola, Qiu Jian, Schirmer Tilman, Silverman Richard B
Division of Structural Biology, Biozentrum, University of Basel, CH-4056 Basel, Switzerland.
Biochemistry. 2004 Nov 9;43(44):14057-63. doi: 10.1021/bi0487185.
(1R,3S,4S)-3-Amino-4-fluorocyclopentane-1-carboxylic acid (7) was previously shown to be a mechanism-based inactivator of gamma-aminobutyric acid aminotransferase (GABA-AT) [Qiu, J. and Silverman, R. B. (2000) J. Med. Chem. 43, 706-720]. Two mechanisms were considered as reasonable possibilities, a Michael addition mechanism and an enamine mechanism. On the basis of a variety of chemical studies, including tedious radiolabeling experiments, it was concluded that inactivation by 7 proceeds by a Michael addition mechanism. Here, a crystal structure of 7 bound to pig liver GABA-AT is reported, which clearly demonstrates that the adduct formed is derived from an enamine mechanism. This represents another example of how crystallography is an important tool for elucidation of inactivation mechanisms.
(1R,3S,4S)-3-氨基-4-氟环戊烷-1-羧酸(7)先前已被证明是一种基于机制的γ-氨基丁酸转氨酶(GABA-AT)失活剂[邱,J.和西尔弗曼,R.B.(2000)《药物化学杂志》43,706 - 720]。有两种机制被认为是合理的可能性,即迈克尔加成机制和烯胺机制。基于包括繁琐的放射性标记实验在内的各种化学研究,得出结论:7的失活是通过迈克尔加成机制进行的。在此,报道了7与猪肝GABA-AT结合的晶体结构,这清楚地表明形成的加合物源自烯胺机制。这代表了晶体学如何成为阐明失活机制的重要工具的又一个例子。